Roshni Khatiwala
Cardiovascular Disease · Sacramento, CANPI 1881154888
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,321 and has fallen 63.2% since, to $1,222 in 2025.
Across 101 payments — averaging $73.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$1K
- Biotronik Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Boston Scientific$912
- Philips North America LLC$507
- Abbott$375
- plus $2K from 12 others
What the payments were for
- Food & beverage$7,453100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 23 | $1,409 |
| Biotronik Inc. | 16 | $1,180 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $1,151 |
| Boston Scientific | 8 | $912 |
| Philips North America LLC | 9 | $507 |
| Abbott | 9 | $375 |
| Medtronic | 2 | $305 |
| Cordis US CORP. | 1 | $264 |
| Heartflow, Inc. | 1 | $203 |
| Abiomed | 2 | $200 |
| Amgen | 2 | $186 |
| E.r. Squibb & Sons, L.L.C. | 4 | $181 |
| Kestra Medical Technology Services, Inc. | 1 | $175 |
| W. L. Gore & Associates, Inc. | 1 | $163 |
| Chiesi USA, Inc. | 2 | $112 |
| Asahi Intecc USA, Inc. | 1 | $64 |
| Novartis | 2 | $38 |
| Pfizer | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$965
- LifeVest$709
- WATCHMAN FLX$440
- Acticor 7 VR-T DX$283
- RAIN SHEATH$264
- BioMonitor$244
- Edora 8 DR-T$224
- FFRct$203
- Assure WCD$175
- COREVALVE EVOLUT R$169
- OPTICROSS$165
- GORE CARDIOFORM Septal Occluder$163
- Perclose ProStyle$162
- ELCA$150
- AMVIA EDGE$137
- AVVIGO Guidance System$137
- ENDURANT IIS$137
- ELIQUIS$125
- Repatha$122
- Impella$114
How this compares
$7,453 in reported general payments places this provider in the 70th percentile of 2,184 cardiovascular disease providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $60,619 |
| JardianceEmpagliflozin | 31 | $33,093 |
| MultaqDronedarone Hcl | 15 | $18,426 |
| Metoprolol Succinate | 113 | $1,969 |
| Rosuvastatin Calcium | 113 | $1,813 |
| Atorvastatin Calcium | 38 | $505 |
| Carvedilol | 28 | $387 |
| Ezetimibe | 15 | $345 |
| ClopidogrelClopidogrel Bisulfate | 20 | $289 |
| Losartan Potassium | 30 | $282 |
| Furosemide | 27 | $271 |
| Nitroglycerin | 13 | $268 |
| Spironolactone | 50 | $247 |
| Amlodipine Besylate | 36 | $185 |
| Torsemide | 15 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $26 | $60,61945 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Sacramento
- Jason RogersSacramento$4.4M
- Gagan SinghSacramento$1.2M
- Thomas SmithSacramento$942K
- Edris AmanSacramento$516K
- Garrett WongSacramento$504K
- William BommerSacramento$194K
- Jeffrey SouthardSacramento$193K
- Andrea SoaresSacramento$159K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.